A new drug has been approved by the European Medicines Agency which could offer better treatment to patients with multiple sclerosis. Alemtuzumab will give people who have the disease the chance to live without the side effects for much longer.
Symptoms of the disease can include loss of physical skills, sensation, vision and bladder control.
Professor Herman Waldmann was involved in the early discovery work of the antibody drug called Campath-1H at Cambridge University. It was originally used to treat leukaemia. He continued to study the drug for two decades while at Oxford University.
More top news
The family of a cyclist who died after he was found with fractured skull and broken ribs has received apology from Chief Constable of Kent.
Charities in the south say it's costing them thousands of pounds every year to deal with rubbish items being left outside their shops.
A nurse who worked at Gosport War Memorial Hospital believes patients could have lived - but management did not listen to her concerns.